These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology]. Yamamoto K; Uchida K; Eguchi F; Shirakawa K Jpn J Antibiot; 1985 Apr; 38(4):1011-6. PubMed ID: 4032717 [TBL] [Abstract][Full Text] [Related]
24. Cefoperazone therapy for obstetric and gynecologic infections. Strausbaugh LJ; Llorens AS Rev Infect Dis; 1983; 5 Suppl 1():S154-60. PubMed ID: 6221385 [TBL] [Abstract][Full Text] [Related]
25. [Clinical studies of cefotaxime, administration in intravenous drip infusion, for infectious diseases in the field of obstetrics and gynecology (author's transl)]. Hagiwara K Jpn J Antibiot; 1981 Apr; 34(4):500-6. PubMed ID: 6270398 [TBL] [Abstract][Full Text] [Related]
26. Experience with cefotaxime in gynecology and obstetrics. Takase Z Clin Ther; 1981; 4 Suppl A():25-44. PubMed ID: 6275996 [TBL] [Abstract][Full Text] [Related]
27. The penicillins. Campbell BA; Cox SM Obstet Gynecol Clin North Am; 1992 Sep; 19(3):435-47. PubMed ID: 1436922 [TBL] [Abstract][Full Text] [Related]
28. Treatment of severe obstetrical and gynaecological septic conditions with brulamycin (tobramycin). Horváth B Ther Hung; 1986; 34(1):39-44. PubMed ID: 3447300 [No Abstract] [Full Text] [Related]
30. [A clinical study on the efficacy of ceftazidime alone or in combination with aspoxicillin against infections in obstetric and gynecological patients]. Chimura T; Hirayama T; Funayama T; Nara N; Miyata R; Kanasugi H; Sato S; Oda T; Saito N; Morisaki N Jpn J Antibiot; 1993 Sep; 46(9):827-35. PubMed ID: 8254902 [TBL] [Abstract][Full Text] [Related]
31. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology]. Yamamoto T; Yasuda J; Tomioka M; Kanao M; Okada H Jpn J Antibiot; 1985 Apr; 38(4):987-94. PubMed ID: 4032735 [TBL] [Abstract][Full Text] [Related]
32. [Ceftazidime: antibacterial activity and clinical efficacy in obstetrics and gynecology]. Ninomiya K; Yoshimoto T; Hasegawa Y Jpn J Antibiot; 1984 Jan; 37(1):14-7. PubMed ID: 6374192 [TBL] [Abstract][Full Text] [Related]
33. [Clinical experience with the use of injectable cephalexin in obstetric and gynecologic pathology]. Tapparelli E; Russo S; D'Alessio L Minerva Ginecol; 1981 Sep; 33(9):851-6. PubMed ID: 7322429 [No Abstract] [Full Text] [Related]
34. [Pharmacokinetic and clinical studies of cefodizime in the field of obstetrics and gynecology]. Iioka H; Moriyama I; Nabuchi K; Katagami Y; Hisanaga H; Tuji Y; Ichijo M Jpn J Antibiot; 1989 Jan; 42(1):208-11. PubMed ID: 2709619 [TBL] [Abstract][Full Text] [Related]
35. Cefotetan in the treatment of obstetric and gynecologic infections. Poindexter AN; Sweet R; Ritter M Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949 [TBL] [Abstract][Full Text] [Related]
39. [Clinical trial of aztreonam in the field of obstetrics and gynecology]. Tateno M; Maruyama C Jpn J Antibiot; 1985 Dec; 38(12):3599-605. PubMed ID: 3834144 [TBL] [Abstract][Full Text] [Related]
40. Metronidazole, clindamycin, and quinolones. Hammill HA Obstet Gynecol Clin North Am; 1989 Jun; 16(2):317-28. PubMed ID: 2674799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]